Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial

Huttner A, Hatz Ch, van den Dobbelsteen G, Abbanat D, Hornacek A, Frölich R et al. The Lancet Infectious Diseases published on line February 23, 2017 Ensayo clínico fase Ib ciego, aleatorio y controlado con placebo para evaluar la seguridad, inmunogenicidad y la eficacia clínica de la vacuna bioconjugada que contiene el antígeno O de…